Skip to nav Skip to content

632 article(s) found

Markers Make Radiation Treatments Shorter and Easier

When patient Howard Curd was told he would need radiation treatment for his esophageal cancer, he feared the worst.

Investigational Drug Service

The Investigational Drug Services pharmacy manages the drugs needed for approximately 300 various early-phase clinical trials administered in Moffitt’s Clinical Research Unit (CRU).

Clinical Research Unit: A Source of Hope

Look in Moffitt’s Clinical Research Unit (CRU), and you’ll find it in the work of a united team doing whatever is necessary to transform hope into reality in the form of cures.

Clinical Research and Patient Safety

As a National Cancer Institute-designated cancer center, Moffitt is charged with conducting investigator-initiated trials, which are designed and managed by the cancer center’s clinical faculty.

Making Progress Against Melanoma?

As Skin Cancer Awareness Month begins, Moffitt continues studies of deadliest form

Patients Furthering Moffitt’s Mission

Data from Total Cancer Care® fuels research efforts.

Herpes Virus Can be Used to Treat Melanoma. Which Cancer is Next?

Since the approval of talimogene laherparepvec (T-VEC, Imlygic®) in 2015, Moffitt has been using this modified form of the herpes virus as a standard treatment for melanoma patients.

Saving Lives After Death

Gail Porter was the first patient to enroll in Moffitt's rapid tissue donation program.

Can Fluorescent Dye Help Detect Ovarian Cancer

This year, more than 22,000 women in the United States will be diagnosed with ovarian cancer.